Ahmedabad

GPAT-2013 PAPER

{Answers are on the end page of question Paper}

Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-centre dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; surgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

Post : Sr Exec, Quality Assurance - IPQA

Troikaa Pharma is a leading company with the remarkable ability to constantly innovate through creative Imagination. Our NDDS brands Dynapar AQ and Dynapar QPS are path breaking & have revolutionised pain care. These innovative products are backed by strong global patents. Continuous focus on innovation and an unwavering commitment to quality has helped Troikaa establish itself both in domestic and international markets. The company is driven by a visionary leadership and a strong multicultural workforce representing more than 70 countries. It's state-of-the-art manufacturing facilities located at Thol, Dehradun and Sanand are accredited by global authorities including WHO, PIC/S, ANVISA Brazil, INVIMA & several other regulatory authorities.

Ishita Drugs & Industries Limited is the flagship company of the ‘Ishita’ Group, which is a respected member of the Indian Business community for more than 3 decades. The Group’s interests encompass manufacturing of a large number of Bulk Actives and their salts, Drug Intermediates etc.

Post : Assistant Manager QC

Space Applications Centre (SAC) is one of the major centres of the Indian Space Research Organisation (ISRO). SAC focuses on the design of space-borne instruments for ISRO missions and development and operationalisation of applications of space technology for societal benefits. The applications cover communication, broadcasting, navigation, disaster monitoring, meteorology, oceanography, environment monitoring and natural resources survey.

Space Applications Centre (SAC), Ahmedabad is one of the leading Centres of Indian Space Research Organisation (ISRO), Department of Space. SAC focuses on the design and development of space borne instruments for terrestrial and planetary missions of ISRO and operationalization of space technology for various applications related to national development.

Post : Pharmacist

Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country. Merck was also the first Merck Group Company to go public in the year 1981.  The Merck Group now holds 51% of the share capital in Merck Limited, while the remaining 49% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.  Merck Specialities Pvt. Ltd., the wholly owned Indian subsidiary of Merck KGaA, was incorporated in 2005.

Post : Area Sales Manager

Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-centre dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; surgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

Post : Associate Manager, R&D - Stability

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India.  Intas' success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades. As of 31st of March 2015, Intas has recorded a turnover of ~Rs.5150 crore* at 21% CAGR over the last 5 years and a profit growth of ~50% CAGR over the same period. Intas is currently ranked 10th in the Indian Pharma Market with 2.80% market share. (as per IMS Health India, Secondary Stockiest Audit (SSA), Nov 16, 2016 MAT).